Purple Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Purple Biotech has a total shareholder equity of $29.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $35.1M and $5.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$6.30m |
| Equity | US$29.47m |
| Total liabilities | US$5.64m |
| Total assets | US$35.11m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1YI's short term assets ($6.9M) exceed its short term liabilities ($5.5M).
Long Term Liabilities: 1YI's short term assets ($6.9M) exceed its long term liabilities ($179.0K).
Debt to Equity History and Analysis
Debt Level: 1YI is debt free.
Reducing Debt: 1YI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1YI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 1YI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.1% each year